<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01127035</url>
  </required_header>
  <id_info>
    <org_study_id>SLITALT2004</org_study_id>
    <nct_id>NCT01127035</nct_id>
  </id_info>
  <brief_title>Sublingual Immunotherapy In Alternaria-Induced Rhinitis</brief_title>
  <official_title>STUDIO IN DOPPIO CIECO DISODIOCROMOGLICATO + PLACEBO vs DISODIOCROMOGLICATO + IMMUNOTERAPIA SPECIFICA SUBLINGUALE PER ALTERNARIA IN PAZIENTI CON RINITE ALLERGICA DOVUTA A SENSIBILIZZAZIONE AD ALTERNARIA</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Genova</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Genova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Respiratory allergy due to Alternaria is a relevant clinical problem, and specific
      immunotherapy may represent a viable treatment option. Sublingual immunotherapy (SLIT) is
      safe and effective, but data for Alternaria are lacking. The study is aimed at assessing the
      efficacy of a standardized SLIT in patients sensitised to Alternaria, in a randomized, double
      blind, placebo controlled fashion.

      Patients with rhinitis with/without intermittent asthma, and ascertained allergy to
      Alternaria are enrolled. After a baseline season, SLIT or matched placebo are given for 10
      months. Symptoms and rescue medication intake are recorded on diary cards from June to
      October. Skin prick test, specific IgE and IgG4 and precipitins are measured at baseline and
      at the end of the study. Alternaria spore count is also performed. Primary outcome is the
      change in symptom score in the active vs placebo group. Secondary outcomes: changes in rescue
      medication intake, alternaria specific IgE and IgG4, skin prick test reactivity.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2006</start_date>
  <completion_date type="Actual">October 2008</completion_date>
  <primary_completion_date type="Actual">October 2008</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>change in symptom score active versus placebo</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in rescue medication intake</measure>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Allergic Rhinitis (w/w Asthma) Due to Alternaria Alternata</condition>
  <arm_group>
    <arm_group_label>SLIT</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>sublingual immunotherapy biologically standardized</description>
  </arm_group>
  <arm_group>
    <arm_group_label>placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>same preparation of SLIT without the allergen</description>
  </arm_group>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>sublingual immunotherapy</intervention_name>
    <arm_group_label>SLIT</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Biological</intervention_type>
    <intervention_name>placebo</intervention_name>
    <arm_group_label>placebo</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Allergic rhinitis

          -  Symptoms May-October

          -  Specific IgE to alternaria (skin test/radioallergosorbent [RAST] test)

          -  Age &gt;14

        Exclusion Criteria:

          -  Sensitization to mites, parietaria, mugwort

          -  Pregnancy-lactation

          -  Malignancies

          -  Chronic systemic steroids

          -  Previous immunotherapy to alternaria
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>14 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Rimini Hospital</name>
      <address>
        <city>Rimini</city>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Tabar AI, Lizaso MT, García BE, Gómez B, Echechipía S, Aldunate MT, Madariaga B, Martínez A. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr Allergy Immunol. 2008 Feb;19(1):67-75. Epub 2007 Jul 25.</citation>
    <PMID>17651380</PMID>
  </reference>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 19, 2010</study_first_submitted>
  <study_first_submitted_qc>May 19, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 20, 2010</study_first_posted>
  <last_update_submitted>June 4, 2010</last_update_submitted>
  <last_update_submitted_qc>June 4, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 7, 2010</last_update_posted>
  <keyword>allergic rhinitis</keyword>
  <keyword>alternaria alternata</keyword>
  <keyword>symptom score</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Rhinitis</mesh_term>
    <mesh_term>Rhinitis, Allergic</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

